The new edition of the Model List of Essential Medicines (EML) , published on 26 July 2023, includes two important medicines for the treatment of alcohol use disorders in adults: acamprosate and naltrexone. Alcohol consumption contributes to 3 million deaths each year globally as well as to the poor health and disabilities of millions of people. It is estimated that worldwide close to 300 million people live with alcohol use disorders, including about 150 million people with alcohol dependence. Until now, no medicines for the treatment of alcohol use disorders have been included in the EML.

https://www.miragenews.com/who-makes-historic-decisions-on-essential-1062705/

#miragenews